285 related articles for article (PubMed ID: 8756628)
21. Critical proline residues of the cytoplasmic domain of the IL-5 receptor alpha chain and its function in IL-5-mediated activation of JAK kinase and STAT5.
Kouro T; Kikuchi Y; Kanazawa H; Hirokawa K; Harada N; Shiiba M; Wakao H; Takaki S; Takatsu K
Int Immunol; 1996 Feb; 8(2):237-45. PubMed ID: 8671609
[TBL] [Abstract][Full Text] [Related]
22. An indispensable role for STAT1 in IL-27-induced T-bet expression but not proliferation of naive CD4+ T cells.
Kamiya S; Owaki T; Morishima N; Fukai F; Mizuguchi J; Yoshimoto T
J Immunol; 2004 Sep; 173(6):3871-7. PubMed ID: 15356135
[TBL] [Abstract][Full Text] [Related]
23. Distinct tyrosine residues within the interleukin-2 receptor beta chain drive signal transduction specificity, redundancy, and diversity.
Gaffen SL; Lai SY; Ha M; Liu X; Hennighausen L; Greene WC; Goldsmith MA
J Biol Chem; 1996 Aug; 271(35):21381-90. PubMed ID: 8702919
[TBL] [Abstract][Full Text] [Related]
24. Differential utilization of Janus kinase-signal transducer activator of transcription signaling pathways in the stimulation of human natural killer cells by IL-2, IL-12, and IFN-alpha.
Yu CR; Lin JX; Fink DW; Akira S; Bloom ET; Yamauchi A
J Immunol; 1996 Jul; 157(1):126-37. PubMed ID: 8683106
[TBL] [Abstract][Full Text] [Related]
25. Activation of Jak/STAT proteins involved in signal transduction pathway mediated by receptor for interleukin 2 in malignant T lymphocytes derived from cutaneous anaplastic large T-cell lymphoma and Sezary syndrome.
Zhang Q; Nowak I; Vonderheid EC; Rook AH; Kadin ME; Nowell PC; Shaw LM; Wasik MA
Proc Natl Acad Sci U S A; 1996 Aug; 93(17):9148-53. PubMed ID: 8799169
[TBL] [Abstract][Full Text] [Related]
26. Tyrosine phosphorylation and activation of JAK family tyrosine kinases by interleukin-9 in MO7E cells.
Yin T; Yang L; Yang YC
Blood; 1995 Jun; 85(11):3101-6. PubMed ID: 7756643
[TBL] [Abstract][Full Text] [Related]
27. Activation of JAK kinases and STAT proteins by interleukin-2 and interferon alpha, but not the T cell antigen receptor, in human T lymphocytes.
Beadling C; Guschin D; Witthuhn BA; Ziemiecki A; Ihle JN; Kerr IM; Cantrell DA
EMBO J; 1994 Dec; 13(23):5605-15. PubMed ID: 7988557
[TBL] [Abstract][Full Text] [Related]
28. Receptors for interleukin (IL)-10 and IL-6-type cytokines use similar signaling mechanisms for inducing transcription through IL-6 response elements.
Lai CF; Ripperger J; Morella KK; Jurlander J; Hawley TS; Carson WE; Kordula T; Caligiuri MA; Hawley RG; Fey GH; Baumann H
J Biol Chem; 1996 Jun; 271(24):13968-75. PubMed ID: 8662928
[TBL] [Abstract][Full Text] [Related]
29. Stimulation of endogenous GH and interleukin-6 receptors selectively activates different Jaks and Stats, with a Stat5 specific synergistic effect of dexamethasone.
von Laue S; Finidori J; Maamra M; Shen XY; Justice S; Dobson PR; Ross RJ
J Endocrinol; 2000 May; 165(2):301-11. PubMed ID: 10810294
[TBL] [Abstract][Full Text] [Related]
30. Distinct roles for STAT1, STAT3, and STAT5 in differentiation gene induction and apoptosis inhibition by interleukin-9.
Demoulin JB; Van Roost E; Stevens M; Groner B; Renauld JC
J Biol Chem; 1999 Sep; 274(36):25855-61. PubMed ID: 10464327
[TBL] [Abstract][Full Text] [Related]
31. Identification of a novel receptor/signal transduction pathway for IL-15/T in mast cells.
Tagaya Y; Burton JD; Miyamoto Y; Waldmann TA
EMBO J; 1996 Sep; 15(18):4928-39. PubMed ID: 8890166
[TBL] [Abstract][Full Text] [Related]
32. Activation of Stat3 in v-Src-transformed fibroblasts requires cooperation of Jak1 kinase activity.
Zhang Y; Turkson J; Carter-Su C; Smithgall T; Levitzki A; Kraker A; Krolewski JJ; Medveczky P; Jove R
J Biol Chem; 2000 Aug; 275(32):24935-44. PubMed ID: 10823829
[TBL] [Abstract][Full Text] [Related]
33. Different interleukin 2 receptor beta-chain tyrosines couple to at least two signaling pathways and synergistically mediate interleukin 2-induced proliferation.
Friedmann MC; Migone TS; Russell SM; Leonard WJ
Proc Natl Acad Sci U S A; 1996 Mar; 93(5):2077-82. PubMed ID: 8700888
[TBL] [Abstract][Full Text] [Related]
34. Role of the interleukin (IL)-28 receptor tyrosine residues for antiviral and antiproliferative activity of IL-29/interferon-lambda 1: similarities with type I interferon signaling.
Dumoutier L; Tounsi A; Michiels T; Sommereyns C; Kotenko SV; Renauld JC
J Biol Chem; 2004 Jul; 279(31):32269-74. PubMed ID: 15166220
[TBL] [Abstract][Full Text] [Related]
35. Critical role of the membrane-proximal, proline-rich motif of the interleukin-2 receptor gammac chain in the Jak3-independent signal transduction.
Tsujino S; Miyazaki T; Kawahara A; Maeda M; Taniguchi T; Fujii H
Genes Cells; 1999 Jun; 4(6):363-73. PubMed ID: 10421845
[TBL] [Abstract][Full Text] [Related]
36. Activation of the protein tyrosine phosphatase SHP2 via the interleukin-6 signal transducing receptor protein gp130 requires tyrosine kinase Jak1 and limits acute-phase protein expression.
Schaper F; Gendo C; Eck M; Schmitz J; Grimm C; Anhuf D; Kerr IM; Heinrich PC
Biochem J; 1998 Nov; 335 ( Pt 3)(Pt 3):557-65. PubMed ID: 9794795
[TBL] [Abstract][Full Text] [Related]
37. The interleukin-4 receptor activates STAT5 by a mechanism that relies upon common gamma-chain.
Lischke A; Moriggl R; Brändlein S; Berchtold S; Kammer W; Sebald W; Groner B; Liu X; Hennighausen L; Friedrich K
J Biol Chem; 1998 Nov; 273(47):31222-9. PubMed ID: 9813029
[TBL] [Abstract][Full Text] [Related]
38. Differences in phosphorylation of the IL-2R associated JAK/STAT proteins between HTLV-I(+), IL-2-independent and IL-2-dependent cell lines and uncultured leukemic cells from patients with adult T-cell lymphoma/leukemia.
Zhang Q; Lee B; Korecka M; Li G; Weyland C; Eck S; Gessain A; Arima N; Lessin SR; Shaw LM; Luger S; Kamoun M; Wasik MA
Leuk Res; 1999 Apr; 23(4):373-84. PubMed ID: 10229324
[TBL] [Abstract][Full Text] [Related]
39. Activation of the Jak-Stat- and MAPK-pathways by oncostatin M is not sufficient to cause growth inhibition of human glioma cells.
Halfter H; Postert C; Friedrich M; Ringelstein EB; Stögbauer F
Brain Res Mol Brain Res; 2000 Sep; 80(2):198-206. PubMed ID: 11038252
[TBL] [Abstract][Full Text] [Related]
40. Constitutive activation of STAT transcription factors in acute myelogenous leukemia.
Spiekermann K; Biethahn S; Wilde S; Hiddemann W; Alves F
Eur J Haematol; 2001 Aug; 67(2):63-71. PubMed ID: 11722592
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
